Avoro Capital Advisors LLC
Filing Date
Global Rank
#547
/ 7,976
▲ 90
Top Industry
Biotechnology
85.1%
3Y Alpha vs SPY
-4.2%
Period ended 9 months ago
Filed Nov 14, 2025 · 7mo
23 quarters · since Mar 2020
Clone Performance
Jun 2023–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+58.7%
SPY
+76.3%
Annualised alpha
-4.2%
Max drawdown
−30.0%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
25 positions · as of Sep 30, 2025 · Δ vs Jun 30, 2025Top Position
15.1%
−2.1 pts
Top 5
59.4%
−3.0 pts
Top 10
82.1%
−1.0 pts
HHI
886
Diversified−67
Portfolio Trend
23 quarters · across all stocks
Sector Breakdown
As of Sep 30, 2025| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $6,750,104,056 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
8 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| CNTA | Centessa Pharmaceuticals plc | +5,808,080 | 10,808,080 | $262,095,940 | |
| OCUL | Ocular Therapeutix, Inc | +2,850,000 | 10,250,000 | $119,822,500 | |
| QURE | uniQure N.V. | +819,444 | 4,444,444 | $259,422,196 | |
| SLNO | Soleno Therapeutics Inc | +527,777 | 2,577,777 | $174,257,725 | |
| ARWR | Arrowhead Pharmaceuticals, Inc. | +300,000 | 10,900,000 | $375,941,000 | |
| ASND | Ascendis Pharma A/S | +130,000 | 5,110,000 | $1,015,919,100 | |
| KRYS | Krystal Biotech, Inc. | +117,777 | 2,777,777 | $490,360,973 | |
| SEPN | Septerna, Inc. | +100,000 | 1,337,500 | $25,158,375 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
10 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| BCRX | Biocryst Pharmaceuticals Inc | −3,250,000 | 1,250,000 | $9,487,500 | |
| FOLD | AMICUS THERAPEUTICS, INC. | −2,975,000 | 15,025,000 | $118,397,000 | |
| MLTX | MoonLake Immunotherapeutics | −2,150,000 | 2,000,000 | $14,340,000 | |
| MNKD | Mannkind Corp | −1,381,123 | 4,468,877 | $23,997,869 | |
| ALKS | Alkermes plc. | −660,000 | 2,240,000 | $67,200,000 | |
| KYMR | Kymera Therapeutics, Inc. | −205,555 | 6,350,000 | $359,410,000 | |
| ARGX | Argenx SE | −185,000 | 990,000 | $730,184,400 | |
| UTHR | UNITED THERAPEUTICS Corp | −147,778 | 2,222,222 | $931,577,684 | |
| VERA | Vera Therapeutics, Inc. | −90,000 | 6,210,000 | $180,462,600 | |
| MDGL | Madrigal Pharmaceuticals, Inc. | −42,000 | 1,833,000 | $840,723,780 | |
| No positions match the current search. | |||||
25 positions ·
$6,750,104,056 total
· as of Sep 30, 2025
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| TNGX |
Tango Therapeutics, Inc.
Healthcare
|
NEW | 545,000 | $4,578,000 | 0.07% | |
| WHWK |
Whitehawk Therapeutics, Inc.
Healthcare
|
Held | 2,849,402 | $5,413,863 | 0.08% | |
| BCRX |
Biocryst Pharmaceuticals Inc
Healthcare
|
Reduced | 1,250,000 | $9,487,500 | 0.14% | |
| MLTX |
MoonLake Immunotherapeutics
Healthcare
|
Reduced | 2,000,000 | $14,340,000 | 0.21% | |
| MNKD |
Mannkind Corp
Healthcare
|
Reduced | 4,468,877 | $23,997,869 | 0.36% | |
| SEPN |
Septerna, Inc.
Healthcare
|
Added | 1,337,500 | $25,158,375 | 0.37% | |
| ORKA |
Oruka Therapeutics, Inc.
Healthcare
|
NEW | 1,333,340 | $25,640,128 | 0.38% | |
| ALKS |
Alkermes plc.
Healthcare
|
Reduced | 2,240,000 | $67,200,000 | 1.00% | |
| TSHA |
Taysha Gene Therapies, Inc.
Healthcare
|
Held | 21,700,000 | $70,959,000 | 1.05% | |
| FOLD |
AMICUS THERAPEUTICS, INC.
Healthcare
|
Reduced | 15,025,000 | $118,397,000 | 1.75% | |
| OCUL |
Ocular Therapeutix, Inc
Healthcare
|
Added | 10,250,000 | $119,822,500 | 1.78% | |
| GPCR |
Structure Therapeutics Inc.
Healthcare
|
NEW | 5,405,555 | $151,355,540 | 2.24% | |
| SLNO |
Soleno Therapeutics Inc
Healthcare
|
Reduced | 2,577,777 | $174,257,725 | 2.58% | |
| VERA |
Vera Therapeutics, Inc.
Healthcare
|
Reduced | 6,210,000 | $180,462,600 | 2.67% | |
| XENE |
Xenon Pharmaceuticals Inc.
Healthcare
|
Held | 5,400,000 | $216,810,000 | 3.21% | |
| QURE |
uniQure N.V.
Healthcare
|
Added | 4,444,444 | $259,422,196 | 3.84% | |
| CNTA |
Centessa Pharmaceuticals plc
Healthcare
|
Added | 10,808,080 | $262,095,940 | 3.88% | |
| APLS |
Apellis Pharmaceuticals, Inc.
Healthcare
|
Held | 12,222,222 | $276,588,883 | 4.10% | |
| KYMR |
Kymera Therapeutics, Inc.
Healthcare
|
Reduced | 6,350,000 | $359,410,000 | 5.32% | |
| ARWR |
Arrowhead Pharmaceuticals, Inc.
Healthcare
|
Added | 10,900,000 | $375,941,000 | 5.57% | |
| KRYS |
Krystal Biotech, Inc.
Healthcare
|
Added | 2,777,777 | $490,360,973 | 7.26% | |
| ARGX |
Argenx SE
Healthcare
|
Reduced | 990,000 | $730,184,400 | 10.82% | |
| MDGL |
Madrigal Pharmaceuticals, Inc.
Healthcare
|
Reduced | 1,833,000 | $840,723,780 | 12.45% | |
| UTHR |
UNITED THERAPEUTICS Corp
Healthcare
|
Reduced | 2,222,222 | $931,577,684 | 13.80% | |
| ASND |
Ascendis Pharma A/S
Healthcare
|
Added | 5,110,000 | $1,015,919,100 | 15.05% |